Display Settings:


Send to:

Choose Destination
See comment in PubMed Commons below
Cancer Immun. 2007 Feb 21;7:4.

Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human colorectal cancer.

Author information

  • Department of Pathology, Mito Medical Center, National Hospital Organization, 280 Sakurano-sato, Ibaraki 311-3193, Japan. hohtani@mito.hosp.go.jp


Human colorectal cancer tissues are infiltrated by various immune/inflammatory cells, usually along the invasive margin. These responses tend be regarded as "non-specific". However, it is now clear that these cellular responses, particularly lymphocytic reactions, are independent prognostic factors for a better survival. Immunohistochemical subset analyses have generally disclosed that the number of T-lymphocytes is important. The effects of these T cells tend to be more manifest when the observation periods are longer. These data suggest that some degrees of anti-tumor immunity exist in human colorectal carcinomas. However, human tumors are generally composed of various histologic subtypes, which sometimes complicates these analyses and simple explanations may be misleading. Considered with precaution, these morphologic analyses on immune cell subtypes are important tools to understand the immune responses in human cancers.

Comment in

[PubMed - indexed for MEDLINE]
Free PMC Article

Images from this publication.See all images (9)Free text

Figure 1;  Immune cell responses in colorectal cancer tissue.
Figure 2;  Immune response observed in areas along the invasive margin.
Figure 3;  Localization of T cells.
Figure 4;  Immune/inflammatory infiltrates in colorectal cancer tissue.
Figure 5;  CD83+ mature DCs in the T cell zone of lymph nodes.
Figure 6;  Significance of a prognostic factor in patients undergoing curative operation.
Figure 7;  Hypothesis on the effects of TILs.
Figure 8;  Inverse association of immune responses and tumor stage.
Figure 9;  Immune responses in tumor tissue may correlate with tumor grade (or de-differentiation status).
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Academy of Cancer Immunology Icon for PubMed Central
    Loading ...
    Write to the Help Desk